E
NOV icon

Ergoteles’s NOV NOV Stock Holding History

Ergoteles’s Portfolio NOV Stock Details NOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-353,199
Closed -$5.67M – 572
2023
Q2 		$5.67M Buy
353,199
+140,571
+66% +$2.29M 0.27% 93
2023
Q1 		$3.94M Buy
212,628
+73,197
+52% +$1.58M 0.15% 113
2022
Q4 		$2.91M Buy
+139,431
New +$2.93M 0.11% 193
2022
Q3 		– Sell
-70,377
Closed -$1.19M – 1840
2022
Q2 		$1.19M Buy
+70,377
New +$1.32M 0.04% 474
2021
Q4 		– Sell
-83,522
Closed -$1.09M – 1479
2021
Q3 		$1.09M Sell
83,522
-34,535
-29% -$466K 0.04% 355
2021
Q2 		$1.81M Buy
+118,057
New +$1.84M 0.04% 383
2021
Q1 		– Sell
-25,947
Closed -$356K – 979
2020
Q4 		$356K Buy
+25,947
New +$293K 0.01% 505

Other funds holding NOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Ergoteles's NOV Position: Q3 2023 in Review

Ergoteles sold out of NOV (NOV) in Q3 2023, closing a stake of 353,199 shares — an estimated $5.67M sold.

Ergoteles first reported a position in NOV in Q4 2020 and held it in 7 quarters. The position peaked at $5.67M in Q2 2023. 365 funds tracked by Wall St. Rank hold NOV as of Q3 2023.

  • Ergoteles reported no remaining NOV position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 353,199 NOV shares in Q3 2023, an estimated $5.67M.
  • Ergoteles first reported a position in NOV in Q4 2020 and held it in 7 quarters.
  • Ergoteles's NOV position peaked at $5.67M in Q2 2023.
  • 365 funds tracked by Wall St. Rank held NOV as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.